Polycystic ovary syndrome (PCOS) is a common but often misunderstood hormonal condition affecting millions of women worldwide. While a diagnosis can provide clarity, it also raises questions about the most effective treatment options.
Two commonly used approaches in PCOS management are metformin and myo-inositol.
This article explores how they compare, what the evidence shows and how each may fit into a personalised PCOS management plan.
Why Insulin Resistance Matters in PCOS
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic condition influenced by hormonal, genetic and metabolic factors.
A central feature in many women with PCOS is insulin resistance.
When the body’s cells do not respond effectively to insulin, higher levels are needed to maintain normal blood glucose.
Elevated insulin can overstimulate the ovaries, increasing androgen production and disrupting ovulation, which may lead to irregular periods, acne, excess hair growth and fertility issues.
Insulin resistance is not limited to women who are overweight; many women with lean PCOS also experience impaired insulin signalling, making metabolic support important for all.
PCOS affects 8–13% of women globally, and it is typically characterised by:
- Irregular or absent menstrual cycles
- Clinical signs of hyperandrogenism, such as acne or excess facial hair
- Polycystic ovarian appearance on ultrasound
While the exact cause remains unclear, PCOS is recognised as a multifactorial condition involving genetic susceptibility, hormonal imbalance and metabolic dysfunction.
Metformin: A Long-Established Medical Therapy
Metformin has been used for decades in the treatment of type 2 diabetes and is commonly prescribed for PCOS, particularly when insulin resistance is prominent.
The medication works by improving the body’s response to insulin and reducing glucose production in the liver. In women with PCOS, metformin has been shown to help:
- Lower insulin levels,
- Reduce excess androgen production and
- Improve menstrual regularity.
Some women also experience modest weight loss and improvements in cholesterol levels, particularly when metabolic risk is higher.
Despite its effectiveness, metformin is not suitable for everyone.
Gastrointestinal side effects such as nausea, bloating and diarrhoea are common, especially when starting treatment.
While these symptoms often settle over time, they can make long-term use challenging for some women.
Myo-Inositol: A Nutritional Support for Hormonal Balance
Myo-inositol is a naturally occurring compound involved in insulin signalling within cells, including ovarian cells.
- In women with PCOS, this signalling pathway is often disrupted, which can impair ovulation and hormone balance.
Supplementing with myo-inositol aims to restore more effective insulin signalling and support normal ovarian function.
Research suggests that myo-inositol can:
- Improve insulin sensitivity at a cellular level
- Promote more regular ovulation
- Support menstrual cycle regulation
- Improve hormonal balance
Myo-inositol is often taken alone or combined with D-chiro-inositol in a ratio that mirrors their natural balance in the body. One of its key advantages is its excellent safety and tolerability profile, making it an appealing option for long-term use or for women who struggle with medication side effects.
How Do Metformin and Myo-Inositol Compare?
Both metformin and myo-inositol can play valuable roles in PCOS management, but their benefits may differ depending on individual circumstances.
Metformin is often most effective for women with:
- Significant insulin resistance,
- Higher androgen levels or
- An increased risk of developing type 2 diabetes.
It may be particularly useful when metabolic health is a primary concern.
Myo-inositol, on the other hand, may be better suited to women who:
- Have milder metabolic symptoms
- Have lean PCOS
- Experience side effects with metformin
Its superior tolerability can make it easier to maintain consistently, which is an important factor in achieving long-term benefits.
Effects on Hormones and Androgen Levels
Excess androgen production lies at the heart of many PCOS symptoms.
By lowering insulin levels, metformin can indirectly reduce ovarian androgen production, often leading to improvements in acne, cycle regularity and ovulation.
Myo-inositol may also help support hormonal balance, although its effects on androgen levels tend to be more subtle when used alone.
When combined with other therapies, including D-chiro-inositol or lifestyle interventions, its hormonal benefits may be enhanced.
Can They Be Used Together?
There is growing interest in using metformin and myo-inositol together, particularly for women with more complex PCOS presentations or those trying to conceive.
Because they work through different mechanisms, combination therapy may offer additional benefits.
Studies in women trying to conceive have shown:
- Improved menstrual regularity
- Better hormonal balance
- Higher ovulation and live birth rates compared with metformin alone
However, combination treatment should always be guided by a healthcare professional.
Looking Beyond Supplements and Medication
While both metformin and myo-inositol can be helpful, neither should be viewed as a complete solution on its own. Sustainable PCOS management requires a holistic approach, with lifestyle factors playing a central role.
Balanced nutrition, regular movement, good-quality sleep and stress management all have a significant impact on insulin sensitivity and hormonal health.
When lifestyle changes are combined with targeted medical or nutritional support, outcomes are consistently better.
Choosing the Right Approach
There is no universal treatment for PCOS.
The decision to use metformin, myo-inositol or a combination of both should be based on individual symptoms, metabolic profile, fertility goals and personal preference.
Working with a qualified healthcare professional allows treatment to be tailored over time, ensuring that it remains effective, tolerable and aligned with long-term health goals.
With the right support and a personalised, evidence-based plan, many women with PCOS can achieve meaningful improvements in symptoms, fertility and overall wellbeing.
